Steven L. Hoerter - Dec 15, 2021 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
President and CEO, Director
Signature
/s/ Jeffrey Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Dec 15, 2021
Transactions value $
$0
Form type
4
Date filed
12/17/2021, 03:10 PM
Previous filing
Aug 16, 2021
Next filing
Jan 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DCPH Common Stock 40.7K Dec 15, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCPH Stock Option (Right to Buy) Award $0 +270K $0.00 270K Dec 15, 2021 Common Stock 270K $9.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was issued pursuant to the Issuer's 2017 Stock Option and Incentive Plan (the "2017 Plan"). The option shall vest in two equal installments on June 15, 2022 and June 15, 2023, subject to continuous service with the Issuer or a Subsidiary (as defined in the 2017 Plan) through each vesting date.